Projects per year
Personal profile
Education
- Ph.D., National Taiwan University
Research Interests
- Tumor Biology
- microRNA
- Molecular cancer therapeutics
Experience
- 2012/07~present Assistant Professor, Department of Medical Laboratory Science and Biotechnology, National Cheng-Kung University
- 2010/08 - 2012/07Postdoctoral Fellow, Department of Oncology, College of Medicine, National Taiwan University
- 2009/02 - 2010/07 Postdoctoral Fellow, Genomic Research Center, College of Medicine, National Taiwan University
Fingerprint Dive into the research topics where Pai-Sheng Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 32 Similar Profiles
Neoplasms
Medicine & Life Sciences
MicroRNAs
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Vascular Endothelial Growth Factor C
Medicine & Life Sciences
Connective Tissue Growth Factor
Medicine & Life Sciences
Neoplasm Metastasis
Medicine & Life Sciences
Vascular Endothelial Growth Factor Receptor-3
Medicine & Life Sciences
Lung Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2012 2018
- 8 Finished
研究 Dicer 蛋白失調在大腸直腸癌進展中的角色: 從功能及調控的探討到可能的治療契機-探討大腸癌中Dicer泛素化依賴之細胞自噬降解途徑之功能性機制(2/3)
17-08-01 → 18-07-31
Project: Research project
研究 Dicer 蛋白失調在大腸直腸癌進展中的角色: 從功能及調控的探討到可能的治療契機-探討大腸癌中Dicer泛素化依賴之細胞自噬降解途徑之功能性機制(1/3)
16-08-01 → 17-07-31
Project: Research project
Research Output 2005 2019
BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
Lin, T. Y., Chan, H. H., Chen, S. H., Sarvagalla, S., Chen, P. S., Coumar, M. S., Cheng, S. M., Chang, Y. C., Lin, C. H., Leung, E. & Cheung, C. H. A., 2019 Jan 1, (Accepted/In press) In : Autophagy.Research output: Contribution to journal › Review article
Open Access
Autophagy
DNA Damage
Fibroblasts
Caspase 3
Neoplasms
Mutation of the PTCH1 gene predicts recurrence of breast cancer
Wang, C. Y., Chang, Y. C., Kuo, Y. L., Lee, K. T., Chen, P. S., Cheung, C. H. A., Chang, C. P., Phan, N. N., Shen, M. R. & Hsu, H. P., 2019 Nov 8, In : Scientific reports. 9, 1, 1 p., 16359.Research output: Contribution to journal › Article
Open Access
Breast Neoplasms
Recurrence
Mutation
Genes
Computational Biology
1
Citation
(Scopus)
TARBP2-enhanced resistance during tamoxifen treatment in breast cancer
Wang, M. Y., Huang, H. Y., Kuo, Y. L., Lo, C., Sun, H. Y., Lyu, Y. J., Chen, B. R., Li, J. N. & Chen, P. S., 2019 Feb, In : Cancers. 11, 2, 210.Research output: Contribution to journal › Article
Open Access
RNA-Binding Proteins
Tamoxifen
HIV-1
Breast Neoplasms
Neurofibromin 2
2
Citations
(Scopus)
TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
Lai, H. H., Li, C. W., Hong, C. C., Sun, H. Y., Chiu, C. F., Ou, D. L. & Chen, P. S., 2019 Apr, In : Molecular Oncology. 13, 4, p. 928-945 18 p.Research output: Contribution to journal › Article
Open Access
RNA-Binding Proteins
Response Elements
Transcriptional Activation
Hepatocellular Carcinoma
Neoplastic Stem Cells
TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
Lai, H., Li, C., Hong, C., Sun, H., Chiu, C., Ou, D. & Chen, P-S., 2019 Jan 18, In : Molecular Oncology.Research output: Contribution to journal › Article